Published in PLoS One on June 24, 2014
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
Dendritic cells and the control of immunity. Nature (1998) 56.54
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54
NCBI GEO: mining tens of millions of expression profiles--database and tools update. Nucleic Acids Res (2006) 19.42
Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med (2005) 12.64
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med (2003) 12.17
Paradoxical roles of the immune system during cancer development. Nat Rev Cancer (2006) 10.57
Natural innate and adaptive immunity to cancer. Annu Rev Immunol (2011) 7.09
Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol (2001) 6.20
Oncology meets immunology: the cancer-immunity cycle. Immunity (2013) 5.60
Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res (2011) 5.30
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol (2005) 4.92
Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol (2008) 4.30
A HaemAtlas: characterizing gene expression in differentiated human blood cells. Blood (2009) 3.63
Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg (2008) 3.21
Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus. PLoS One (2009) 2.98
Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun (2005) 2.69
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol Immunother (2008) 2.54
Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med (1981) 2.50
Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol (2006) 2.37
Prognostic immune markers in non-small cell lung cancer. Clin Cancer Res (2011) 2.03
The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol Med (2007) 1.91
Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res (2009) 1.86
Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol (2012) 1.80
Dendritic cell dysfunction in cancer: a mechanism for immunosuppression. Immunol Cell Biol (2005) 1.67
Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg (1993) 1.64
Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma. Clin Cancer Res (2005) 1.59
Prognostic DNA methylation biomarkers in ovarian cancer. Clin Cancer Res (2006) 1.53
Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms. Ann Thorac Surg (2009) 1.40
CellMix: a comprehensive toolbox for gene expression deconvolution. Bioinformatics (2013) 1.40
Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization. Clin Cancer Res (2005) 1.38
Semi-supervised Nonnegative Matrix Factorization for gene expression deconvolution: a case study. Infect Genet Evol (2011) 1.33
Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol (1995) 1.26
Immune cell infiltrates and prognosis in primary carcinoma of the lung. Lung Cancer (2000) 1.25
Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol Immunother (2007) 1.21
Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991. J Neurosurg (1995) 1.19
Autologous dendritic cell vaccines for non-small-cell lung cancer. J Clin Oncol (2004) 1.18
HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer. Cancer Sci (2007) 1.16
The transcriptome in blood: challenges and solutions for robust expression profiling. Curr Mol Med (2005) 1.13
The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol (1998) 1.05
Translational applications of flow cytometry in clinical practice. J Immunol (2012) 1.00
Peripheral immune cell gene expression predicts survival of patients with non-small cell lung cancer. PLoS One (2012) 0.96
Cryopreservation and long-term liquid nitrogen storage of peripheral blood mononuclear cells for flow cytometry analysis: effects on cell subset proportions and fluorescence intensity. J Clin Lab Anal (1991) 0.91
Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer. Hum Pathol (2001) 0.90
The peripheral immune response and lung cancer prognosis. Oncoimmunology (2012) 0.86
Intratumoral T cells and survival in epithelial ovarian cancer. Natl Med J India (2003) 0.78
The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2. Oncotarget (2015) 0.97
Network-based survival-associated module biomarker and its crosstalk with cell death genes in ovarian cancer. Sci Rep (2015) 0.87
Systematic interpretation of comutated genes in large-scale cancer mutation profiles. Mol Cancer Ther (2010) 0.81
A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources. Oncotarget (2016) 0.79
Functional comparison between genes dysregulated in ulcerative colitis and colorectal carcinoma. PLoS One (2013) 0.76
Application of the rank-based method to DNA methylation for cancer diagnosis. Gene (2014) 0.75